Cargando…
What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli
There are striking similarities between the dual pandemics of multidrug-resistant tuberculosis (MDR TB) and multidrug-resistant Gram negative bacilli (MDR GNB) despite fundamental differences in the pathogenesis and epidemiology of these pathogens. In this perspective, we highlight several strategie...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850263/ https://www.ncbi.nlm.nih.gov/pubmed/31723682 http://dx.doi.org/10.1016/j.jctube.2016.03.004 |
_version_ | 1783469386543136768 |
---|---|
author | Banerjee, Ritu Starke, Jeffrey R. |
author_facet | Banerjee, Ritu Starke, Jeffrey R. |
author_sort | Banerjee, Ritu |
collection | PubMed |
description | There are striking similarities between the dual pandemics of multidrug-resistant tuberculosis (MDR TB) and multidrug-resistant Gram negative bacilli (MDR GNB) despite fundamental differences in the pathogenesis and epidemiology of these pathogens. In this perspective, we highlight several strategies that have been used by the global TB community to address the MDR TB problem, including approaches to: encourage appropriate use of anti-TB medications, enhance appropriate utilization of molecular diagnostic testing, facilitate development of new antimicrobial agents, and strengthen surveillance systems and infection control practices. Understanding the successes and challenges of these strategies for MDR TB control will be instructive for efforts to curb emergence and spread of MDR GNB. |
format | Online Article Text |
id | pubmed-6850263 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-68502632019-11-13 What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli Banerjee, Ritu Starke, Jeffrey R. J Clin Tuberc Other Mycobact Dis Article There are striking similarities between the dual pandemics of multidrug-resistant tuberculosis (MDR TB) and multidrug-resistant Gram negative bacilli (MDR GNB) despite fundamental differences in the pathogenesis and epidemiology of these pathogens. In this perspective, we highlight several strategies that have been used by the global TB community to address the MDR TB problem, including approaches to: encourage appropriate use of anti-TB medications, enhance appropriate utilization of molecular diagnostic testing, facilitate development of new antimicrobial agents, and strengthen surveillance systems and infection control practices. Understanding the successes and challenges of these strategies for MDR TB control will be instructive for efforts to curb emergence and spread of MDR GNB. Elsevier 2016-04-01 /pmc/articles/PMC6850263/ /pubmed/31723682 http://dx.doi.org/10.1016/j.jctube.2016.03.004 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Banerjee, Ritu Starke, Jeffrey R. What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli |
title | What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli |
title_full | What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli |
title_fullStr | What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli |
title_full_unstemmed | What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli |
title_short | What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli |
title_sort | what tuberculosis can teach us about combating multidrug-resistant gram negative bacilli |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850263/ https://www.ncbi.nlm.nih.gov/pubmed/31723682 http://dx.doi.org/10.1016/j.jctube.2016.03.004 |
work_keys_str_mv | AT banerjeeritu whattuberculosiscanteachusaboutcombatingmultidrugresistantgramnegativebacilli AT starkejeffreyr whattuberculosiscanteachusaboutcombatingmultidrugresistantgramnegativebacilli |